A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis - Join Clinical Trial NCTNCT04123795
How to Join This Clinical Trial - NCTNCT04123795
Learn how to participate in this PHASE3 trial studying an investigational therapy for Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE3 - Large-scale efficacy study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT04123795 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 51 locations. Find a study site near you:
Clinical Research Site
Auburn, Alabama 36832 - United States
Status: WITHDRAWN
Clinical Research Site
Phoenix, Arizona 85006 - United States
Status: COMPLETED
Clinical Research Site
Anaheim, California 92804 - United States
Status: WITHDRAWN
Clinical Research Site
Fountain Valley, California 92708 - United States
Status: RECRUITING
Clinical Research Site
Los Angeles, California 90045 - United States
Status: RECRUITING
Clinical Research Site
Thousand Oaks, California 91320 - United States
Status: RECRUITING
Clinical Research Site
Aurora, Colorado 80012 - United States
Status: WITHDRAWN
Clinical Research Site
Boca Raton, Florida 33428 - United States
Status: RECRUITING
Clinical Research Site
Hialeah, Florida 33016 - United States
Status: RECRUITING
Clinical Research Site
Jacksonville, Florida 32256 - United States
Status: RECRUITING
And 41 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE3 clinical trial for Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships